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Gonorrhea 
Recommen~ed Treatment Schedules-1974 
We have been asked by the Venereal Disease Control Division of the Center for Disease Control, 
Atlanta. Georgia. to publish the following material. 
Physicians ate cautioned to use no less than the recommended dosages of antibiotics. 
UNCOMPLICATED GONOCOCCAL [!\FECTJONS IN MEN 
AND WOMEN 
Drug Regimen of Choice: 
Aqueous procaine penicillin G (APPG). 4.8 mil-
lion units intramuscularly. divided into at least 
two doses and injected ~t different sites at one 
visit. together with one gram o( probenecid, by 
mouth. just before the injections. 
Alternative Regimens: 
A. Patients in whom oral therap~' is preferred: 
Ampicillin. 3.5 I'm. by mouth, together with 
one gram probenecid by mouth, adminis-
tered at the same time. There is evidence 
that this regimen may be slightly less effec-
tive then the recommended APPG regimen. 
B. Patients who are allergic to the penicillins 
(penicillin G. ampicillin) or probenecid': 
1. Tetracycline hydrochloride, 1.5 I'm ini-
tially by mouth. followed by 0.5 gm by 
mouth four times per day for 4 davs (total 
dosage, 9.5 gm). Other tetracyclines are 
not more effective than tetracycline hy-
drochloride. All tetracyclines are ineffec-
tive as single-dose the;apy. 
2. Spectinomycin hydrochloride. 2.0 I'm in-
tramuscularly, in one injection. 
Treatment of Sexual Partners: 
Men and women with known recent exposure to 
gonorrhea shou ld receive the same treatment as 
individuals known to have gonorrhea. Male sex 
partners of persons with gonococcal infection must 
be examined and treated because of the high 
prevalence of non symptomatic urethral gonococcal 
infection in such men. 
• Allergy to penicillin, ampicillin, probenecid. or previ-
ous anaphylactic reaction. 
Followup: 
Followup urethral and other appropriate cul-
tures should be obtained from men. and cervical. 
anal. and other appropriate cultures should be 
obtained from women. 7 to 14 days after comple-
tion of treatment. 
Treatment Failures: 
Most recurrent infection after treatment with 
the recommended schedules is due to reinfection. 
True treatment failure after therapy with penicil-
lin, ampicillin. or tetracycline should be treated 
with 2.0 gm of spectinomycin intramuscularly. 
Pastgonococcal Urethritis.' 
Tetracycline, 0.,,) I'm, four times daily by mouth, 
for at least 7 days. 
Pharyngeal Infection: 
Pharyngeal gonococcal infections may be more 
difficult to treat than anogenital gonorrhea. Post-
treatment cultures are essential followup l(.r pha-
ryngeal infection. The schedules of ampicillin and 
spectinomycin recommended for anogenital gonor-
rhea are ineffective in pharyngeal gonorrhea. Pa-
tients with pharyngeal gonorrhea whose infection 
is not eradicated after treatment with 4.8 million 
units of APPG plus one gram of probenecid, may 
be treated with 9.5 gm of tetracycline in the dosage 
schedule outlined above (Alternative Regimens). 
Syphilis: 
All patients with gonorrhea should have a sero-
logic test for syphilis at the time of diagnosis. 
Seronegative patients without clinical signs of 
syphilis, who are receiving the recommended par-
enteral penicillin schedule, need not have fol-
lowup serologic tests for syphilis. Patients treated 
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with ampicillin, spectinomycin. or tetracycline 
should have a followup serologic test for syphilis 
~f'ter 3 months to detect untreated syphilis. 
Patients with gonorrhea who also have syphilis 
,hould be given additional treatment appropriate 
to the stage of syphilis. 
Not Recommended: 
Although long-acting forms of penicillin (such as 
benzathine penicillin G) are effective in syph-
ilotherapy. they have NO place in the treatment 
of gonorrhea. Oral penicillin preparations such as 
penicillin V are not recommended for the treat-
ment of gonococcal infection. 
TREATME~T OF Ur--;COMPLICATED GOr--;ORRHEA IN 
PREGNAr--;T PATIECiTS 
A. For women who are not allergic to penicillin: 
Use the regimens of aqueous procaine peni-
cillin G plus probenecid. or use ampicillin plus 
prohenecid. as defined above. 
B. Pregnant patients who are allergic to penicil-
lins (there are several possible alternative 
regimens. each of which has potential disad-
vantages) : 
1. Erythromycin, 1.5 gm orally_ followed by 
0.5 gm four times a day for 4 days. filr a 
total of 9.5 gm. This regimen is safe for 
mother and fetus. but efficacv has not 
heen established. Ervthromvci'n estolate 
should not be used in patient~ with under-
lying liver disease. 
2. Cefazolin. 2 gm intramuscularly. with 1.0 
gm of probenecid. Because of the possibil-
ity of cross-allergenicity between penicil-
lins and cephalosporins, this regimen 
should not be used in a patient with a 
history of penicillin anaphylaxis. 
3. Spectinomycin. 2 gm intramuscularly. 
This is an effective dose, but safety for the 
fet us has not been established. 
Contraindicated: 
Tetracycline should not be used for uncom-
plicated gonococcal infection in pregnancy because 
of potential toxic effects for mother and fetus. 
ACUTE SALPINGITIS (PELVIC Ir-:FLAMMATORY 
DISEASE) 
The diagnosis of acute salpingitis should be con-
sidered in women with acute lower abdominal pain 
and adnexal tenderness on pelvic examination. 
Since there are no completely reliable clinical cri-
teria on which to distinguish gonococcal from non-
gonococcal salpingitis. endocervical cultures for N. 
{!onorrhoeae are essential in such patients. Ther-
apy. however. should be initiated immediately, 
without waiting for the results of the cultures. 
A. Hospitalization: Hospitalization should be 
strongly considered for women with sus-
pected salpingitis in these situations: 
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1. Uncertain diagnosis, where surgical emer-
gencies must be excluded. 
2. Suspicion of pelvic abscess. 
3. Pregnant patients with salpingitis. 
4. Inability of the patient to follow an 
outpatient regimen of oral medication. 
especially because of nausea and 
vomiting. 
5. Failure to respond to outpatient therapy. 
B. Antimicrobial Agents: Controlled studies of 
the treatment of acute salpingitis are not 
available. Initial management must AT 
LEAST be adequate for gonococcal 
salpingitis. These regimens are known to be 
adequate for the treatment of gonococcal 
salpingitis: 
1. Outpatients: 
a. 1.5 gm tetracycline hydrochloride. 
given as a single oral loading dose. 
followed by 500 mg. taken orally, four 
times daily for 10 days. 
b. Aqueous procaine penicillin G 
(APPG). 4.8 million units intramuscu-
larly, divided into at least two doses and 
and injected at different sites at one 
visit OR 3_5 gm of oral ampicillin. One 
gram of oral probenecid is given along 
with either penicillin or ampicillin. and 
both are followed by 500 mg of ampicil-
lin. taken orally, four times daily for 10 
days. 
2. Hospitalized patients: 
a. Aqueous crystalline penicillin G, 20 
million units, given intravenously each 
day until clear-cut improvement 
occurs, followed by 500 mg of 
ampicillin taken orally four times 
daily. to complete 10 days of therapy. 
The need for additional or alternative 
antibiotics for the treatment of 
nongonococcal sal pingitis requires 
further study. Since it is impossible to 
distinguish gonococcal from nongono-
coccal salpingitis clinically. many physi-
cians also use an aminoglycoside in addi-
tion to penicillin and/or antibiotics 
which are effective against Bacteroides 
tragilis as initial therapy. 
b. Tetracycline hydrochloride, 500 mg. 
given intravenously four times daily 
until improvement occurs, followed by 
500 mg taken orally four times daily. to 
complete 10 days of therapy. This 
regimen should not be used for 
pregnant women or for patients with 
renal failure. 
3. Failure to improve on the recommended 
regimens does not necessarily indicate the 
need for stepwise additional antibiotics, 
but requires reassessment of the 
possibility of other diagnoses and of the 
specific microbial etiology. 
C. The effect of the removal of an intrauterine 
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device on the response of acute salpingitis to 
antimicrobial therapy and on the risk of 
recurrent salpingitis requires further study. 
D. Adequate treatment of women with acute 
gonococcal salpingitis must include 
examination and appropriate treatment of 
their male sex partners because of the high 
prevalence of nonsymptomatic urethral 
gonococcal infection in such men. Failure to 
treat male sex partners is a major cause of 
recurrent gonococcal salpingitis. 
E. Followup of patients with acute salpingitis is 
essential. All patients should receive repeat 
pelvic examinations and cultures for N. 
gonorrhoeae after treatment. 
DISSEMINATED GONOCOCCAL INFECTION 
A. Equally effective treatment schedules in the 
arthritis-dermatitis syndrome include: 
1. Aqueous crystalline penicillin G, 10 
million units intravenously per day for 3 
days, or until there is significant clinical 
improvement. This may be followed with 
ampicillin, 500 mg four times a day orally, 
to complete 7 days of antibiotic 
treatment. 
2. Ampicillin, 3.5 gm orally, plus pro-
benecid, 1.0 gm, followed by ampicil-
lin, 500 mg four times per day orally, 
for at least 7 days_ 
B. In penicillin and/or probenecid allergic 
patients: 
1. Tetracycline, 1.5 gm orally. followed by 
500 mg four times a day orally, for at least 
7 days. Tetracycline should not be used for 
complicated gonococcal infection in 
pregnancy because of potential toxic 
effects for mother and fetus. 
2. Erythromycin, 0.5 gm intravenously every 
6 hours, for at least 3 days. 
C. Additional measures: 
1. Hospitalization is indicated in patients 
who are unreliable, have uncertain 
diagnosis, or have purulent joint effusions 
or other complications. 
2. Immobilization of the affected joint(s) 
appears helpful. Repeated aspirations and 
saline irrigations appear beneficial, but 
controlled studies of these procedures 
have not been performed. Open drainage 
of joints other than the hip is now 
generally discouraged in patients with 
gonococcal arthritis. 
3. Intra-articular administration of 
penicillin is unnecessary, since penicillin 
levels in the synovial fluid of inflamed 
Jomts approximate serum levels; 
furthermore, intra-articular injection per 
se may produce a toxic synovitis. 
D. Meningitis and endocarditis due. to the 
gonococcus require high-dose intravenous 
penicillin therapy (at least 10 million units 
Vol. 64, No.2 
per day) for longer periods: usually at least 10 
days for meningitis and 3-4 weeks for 
endocardi tis. 
GONOCOCCAL INFECTION IN PEDIATRIC PATIENTS 
Pediatric patients encompass those from birth to 
adolescence. When a child is post-pubertal and/or 
weighs over 100 pounds, he or she should be treated 
with dosage regimens as defined above for adults. 
With gonococcal infection in children, the pos-
sibility of child abuse must be considered! 
The efficacy of therapeutic regimens for uncom-
plicated and complicated gonococcal infections of 
childhood is unproven at present. 
Prevention of Neonatal Infection: 
All pregnant women should have endocervical 
cultures examined for gonococci as an integral part 
of prenatal care. 
Prevention of Gonococcal Ophthalmia: 
A. One percent silver nitrate (do not Irngate 
with saline. as this may reduce efficacy). 
B. Ophthalmic ointments containing tetracy-
cline, erythromycin, or neomycin are also 
probably effective. 
C. NOT RECOMMENDED: Bacitracin oint-
ment (not effective) and penicillin drops 
(sensitizing). 
Management of Infants Born to Mothers With 
Gonococcal Infection: 
Orogastric and rectal cultures should be taken 
from all patients. Blood cultures should be taken if 
septicemia is suspected. Aqueous crystalline peni-
cilin G, 50,000 units/kg/day, should be adminis-
tered in two daily doses intravenously, if cultures 
or Gram-stained smears reveal gonococci. The 
duration of therapy should be determined by 
clinical response. In suspected septicemia, an ami-
noglycoside should also be administered. 
Neonatal Disease: 
A. Gonococcal ophthalmia: Patient should be 
hospitalized. Antimicrobial agents: Aqueous 
crystalline penicillin G, 50,000 units/kg/day, 
in two or three doses intravenously for 7 days, 
PLUS frequent saline irrigations and instilla-
tion of penicillin. tetracycline or chloram-
phenicol eyedrops. 
B. Complicated infection: Arthritis and sep-
ticemia should be treated by hospitalization 
and administration of aqueous crystalline 
penicillin G, 75,000-100,000 units/kg/day, in 
four doses, or procaine penicillin G, 
75,000-100,000 units/kg/day, in two doses, 
for 7 days. Meningitis should be treated with 
aqueous crystalline penicillin G, 100,000 
units/kg/day, divided into two or three daily 




Gonococcal ophthalmia should be treated with 
hospitalization and by the administration of aque· 
'>Us crystalline penicillin G intravenously, 
i5,000-100,OOO units/kg/day, in four doses, or pro· 
caine penicillin G, intramuscularly, 75,000-100,000 
clOits/kg/day, in two doses, for 7 days, PLUS saline 
,rrigations and instillation of penicillin, tetracy-
line or chloramphenicol eyedrops. Topical antibi-
,tics alone are NOT recommended in therapy of 
"onococcal ophthalmitis. The source of the infec-
. ion must be identified. 
Uncomplicated vulvovaginitis and urethritis 
usually do not require hospitalization. Both may 
be treated at one visit with aqueous procaine 
penicillin G, 75,000-100,000 units/kg intramuscu-
larly, and probenecid, 25 mg/kg by mouth. Topical 
and systemic estrogen therapy are of no benefit in 
vulvovaginitis. All patients should have followup 
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cultures, and the source of infection should be 
identified, examined and treated. 
Infection complicated by peritonitis or arthritis 
should be treated by hospitalization and adminis-
tration of aqueous crystalline penicillin G, intrave-
nously, 75,000-100,000 units/kg/day, in four doses, 
or procaine penicillin G, 75,000-100,000 units/kg/ 
day intramuscularly, in two doses for 7 days. 
Treatment of patients with allergy to penicillin: 
Patients under 6 years of age should be treated 
with erythromycin, 40 mg/kg/day, in four doses by 
mouth, for 7 days, for uncomplicated disease. 
Complicated disease should be treated with cepha-
lothin, 60-80 mg/kg/day in four doses intrave-
nously, for 7 days. Patients older than 6 may be 
treated with an oral regimen of tetracycline, 25 
mg/kg, as an initial dose, followed by 40-60 mg/kg/ 
day in four doses, for 7 days, or an intravenous 
regimen consisting of tetracycline, 15-20 mg/kg/ 
day, in four doses, for 7 days. 
